» Articles » PMID: 11375765

Bauhinia Bauhinioides Plasma Kallikrein Inhibitor: Interaction with Synthetic Peptides and Fluorogenic Peptide Substrates Related to the Reactive Site Sequence

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2001 May 29
PMID 11375765
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

A serine proteinase inhibitor was purified from Bauhinia bauhinioides seeds after extraction with 0.15M NaCl by ion-exchange column chromatography on DEAE-Sephadex, gel filtration on Superose 12 column, Mono Q chromatography or alternatively by affinity chromatography on trypsin- Sepharose. The inhibitor is a single polypeptide chain with molecular mass 20 kDa by gel filtration on Superose 12, but was resolved into two peaks by ion - exchange chromatography on Mono Q (FPLC system). The main eluted peak inhibits trypsin (Ki = 0.6 nM), plasma kallikrein (Ki = 0.35 nM), plasmin (Ki = 33.1 nM), and weakly chymotrypsin (Ki = 2,700 nM), being the most effective plasma kallikrein inhibitor isolated from Bauhinia seeds. Therefore, it was denominated Bauhinia bauhinioides kallikrein inhibitor (BbKI). Activity is thermolabile and on trypsin inhibition optimum pH is 8.0. BbKI displays high homology to other plant Kunitz inhibitors, except for the absence of disulfide bridges, and the only cysteine residue is at the C-terminal position (residue 154) characterizes a distinct member of the Kunitz family. The affinity of the inhibitor to trypsin was confirmed by adsorption to trypsin-Sepharose resin and by isolation of the trypsin-inhibitor complex by gel filtration. Peptides with variations around the reactive site of BbKI (GLPVRFESPLRINIIKESY) were synthesized containing a quenched fluorogenic group. Trypsin but not plasma kallikrein substrates, these peptides strongly inhibited plasma kallikrein.

Citing Articles

Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from (pep-BbKI) in an Asthma-COPD Overlap (ACO) Model.

da Silva L, Barbosa J, Joao J, Fukuzaki S, do Nascimento Camargo L, Dos Santos T Int J Mol Sci. 2023; 24(14).

PMID: 37511021 PMC: 10379932. DOI: 10.3390/ijms241411261.


Plant-Derived Compounds and Extracts as Modulators of Plasmin Activity-A Review.

Kolodziejczyk-Czepas J, Czepas J Molecules. 2023; 28(4).

PMID: 36838662 PMC: 9965408. DOI: 10.3390/molecules28041677.


"Cow's Hoof" ( L., Leguminosae): A Review on Pharmacological Properties of Austral South American Species.

Fortunato R, Nores M Plants (Basel). 2023; 12(1).

PMID: 36616160 PMC: 9823647. DOI: 10.3390/plants12010031.


Structural studies of complexes of kallikrein 4 with wild-type and mutated forms of the Kunitz-type inhibitor BbKI.

Li M, Srp J, Mares M, Wlodawer A, Gustchina A Acta Crystallogr D Struct Biol. 2021; 77(Pt 8):1084-1098.

PMID: 34342281 PMC: 8329858. DOI: 10.1107/S2059798321006483.


Crystal structures of the complex of a kallikrein inhibitor from Bauhinia bauhinioides with trypsin and modeling of kallikrein complexes.

Li M, Srp J, Gustchina A, Dauter Z, Mares M, Wlodawer A Acta Crystallogr D Struct Biol. 2019; 75(Pt 1):56-69.

PMID: 30644845 PMC: 6333282. DOI: 10.1107/S2059798318016492.